Platinum-refractory Ovarian Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-06-18
Clinical Trial Update: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents [Phase 2]
Phase 2 study comparing standard of care versus a triplet targeted immunotherapy combination in Fallopian tube mucinous adenocarcinoma and o…